Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19414726
Conclusion of this study
In this pharmacogenetic study, riboflavin appears to be more effective in patients with migraine with non-H mitochondrial DNA haplotypes. The underlying mechanisms are unknown, but could be related to the association of haplogroup H with increased activity in complex I, which is a major target for riboflavin. Our results may have ethnic implications, since haplogroup H is chiefly found in the European population.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study